Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Of talking cows and missing antidepressants
October 11, 2012
By: Gil Roth
President, Pharma & Biopharma Outsourcing Association
I spent some of my summer reading the classic Romans and pining for my old days studying the Attic Greeks. As I mentioned in last issue’s What I’m Reading sidebar, you can learn plenty about our modern state of affairs from Livy’s history of early Rome. At several points, I found myself laughing over some of the odder plagues and auguries that struck the Romans. In Book 3 of Livy, we find:
The year was marked with ominous signs: fires blazed in the sky, there was a violent earthquake, and a cow talked — there was a rumor that a cow had talked the previous year, but nobody believed it: this year they did. Nor was this all: it rained lumps of meat. Thousands of birds (we are told) seized and devoured the pieces in mid-air, while what fell to the ground lay scattered about for several days without going putrid.
Greece’s state-administered healthcare system operates only 10 pharmacies that dispense pre-paid mood stabilizers and other medications. The country’s approximately 9,000 privately owned pharmacies demand cash that customers can recoup from the government insurance fund. Neither scheme works. The reason, of course, is money. There is none. According to the Pharmacies’ Association in Athens, major drug makers are no longer keen to trade with Greece . . . The whereabouts of stockpiled anti-depressants are mostly a mystery and independent pharmacists gripe that the government currently owes them some €540 million. . . . “It makes it difficult for the government to provide people with medication,” Kanellakis says.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !